Literature DB >> 8564487

Human saphenous vein organ culture: a useful model of intimal hyperplasia?

K E Porter1, K Varty, L Jones, P R Bell, N J London.   

Abstract

OBJECTIVES: Although cell culture techniques and animal models of intimal hyperplasia have increased our current understanding of the aetiology of vein graft stenosis, the results of such studies have been difficult to relate to the human situation.
DESIGN: The present study was designed to validate an organ culture of human saphenous vein by comparing the changes occurring in cultured vein with those seen in pathological vein graft stenoses and to identify a suitable marker of cell proliferation.
MATERIALS AND METHODS: Saphenous vein segments were cultured for 14 days, fixed in formalin and processed for immunohistochemistry. Freshly excised stenoses were fixed and processed similarly. A number of markers of cell proliferation were evaluated in the culture system in order to identify the one best suited to this particular model.
RESULTS: Marked similarities were observed in the cellular and extracellular matrix composition, and electron microscopy revealed that both the neointima of the cultured vein and the pathological lesion contained an abundance of smooth muscle cells of a secretory phenotype. Bromodeoxyuridine proved to be the most reliable proliferation marker and revealed that early proliferation in the superficial layers of the vein intima gave rise to the formation of neointima. Both proliferation and neointimal thickness were maximal by day 14 in culture. Proliferation declined rapidly thereafter, and the neointima was maintained.
CONCLUSIONS: The changes occurring in cultured vein and graft stenoses bore many similarities, thereby justifying the use of organ culture as a valuable experimental tool.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564487     DOI: 10.1016/s1078-5884(96)80134-1

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  18 in total

1.  A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.

Authors:  Luciana B Lopes; Colleen M Brophy; Charles R Flynn; Zhengping Yi; Benjamin P Bowen; Christopher Smoke; Brandon Seal; Alyssa Panitch; Padmini Komalavilas
Journal:  J Vasc Surg       Date:  2010-09-22       Impact factor: 4.268

2.  Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.

Authors:  Sun Hyung Kwon; Li Li; Yuxia He; Chieh Sheng Tey; Huan Li; Ilya Zhuplatov; Seung-Jung Kim; Christi M Terry; Donald K Blumenthal; Yan-Ting Shiu; Alfred K Cheung
Journal:  J Vasc Res       Date:  2016-01-21       Impact factor: 1.934

3.  Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia.

Authors:  B Kumar; K Dreja; S S Shah; A Cheong; S-Z Xu; P Sukumar; J Naylor; A Forte; M Cipollaro; D McHugh; P A Kingston; A M Heagerty; C M Munsch; A Bergdahl; A Hultgårdh-Nilsson; M F Gomez; K E Porter; P Hellstrand; D J Beech
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

4.  Mechanical and biocompatible characterizations of a readily available multilayer vascular graft.

Authors:  Krishna Madhavan; Winston H Elliott; Walter Bonani; Eric Monnet; Wei Tan
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2012-11-19       Impact factor: 3.368

5.  Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.

Authors:  Daniel J Wong; Daniel Y Lu; Clinton D Protack; Go Kuwahara; Hualong Bai; Nirvana Sadaghianloo; George Tellides; Alan Dardik
Journal:  J Vasc Surg       Date:  2014-10-24       Impact factor: 4.268

6.  Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.

Authors:  Michael J Osgood; Kevin Sexton; Igor Voskresensky; Kyle Hocking; Jun Song; Padmini Komalavilas; Colleen Brophy; Joyce Cheung-Flynn
Journal:  J Vasc Surg       Date:  2016-08       Impact factor: 4.268

7.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

8.  Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration.

Authors:  Yujun Cai; Walter E Knight; Shujie Guo; Jian-Dong Li; Peter A Knight; Chen Yan
Journal:  J Pharmacol Exp Ther       Date:  2012-08-22       Impact factor: 4.030

9.  Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein.

Authors:  Michael J Osgood; Kyle M Hocking; Igor V Voskresensky; Fan Dong Li; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  J Vasc Surg       Date:  2013-07-30       Impact factor: 4.268

10.  MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein.

Authors:  Thomas S Monahan; Nicholas D Andersen; Michelle C Martin; Junaid Y Malek; Gautam V Shrikhande; Leena Pradhan; Christiane Ferran; Frank W LoGerfo
Journal:  FASEB J       Date:  2008-10-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.